A population-based analysis of the adverse effects and adherence of novel diabetes therapy in older persons with cardiovascular disease

Principal investigator: Jackevicius CA
Co-investigators: Atzema CL, Austin PC, Booth GL, Ko D, Naimark DM, Stukel TA, Tu K, Udell JA

Canadian Institutes of Health Research, Project Grant
2021-2024; $367,200

Comprehensive diabetes management and its association with the risk of leg amputation: a population-based cohort study

Principal investigator: de Mestral C
Co-investigators: Albalawi Z, Al-Omran M, Austin PC, Caul JM, Cross KM, Evans R, Lee DS, Verma SS

Canadian Institutes of Health Research, Project Grant
2021-2023; $130,050

Prescribing cascades: putting the pieces together to optimize prescribing

Principal investigators: Hillmer M, Rochon PA
Co-investigators: Austin PC, Bell CM, Giannakeas V, Gruneir A, Hayes A, McCarthy L, Savage R, Stall NM

Canadian Institutes of Health Research, Project Grant
2021-2024; $493,425

Recent Awards & Recognition

Clarivate Analytics Highly Cited Researchers 2022

2022: Dr. Peter Austin was selected by Clarivate Analytics as one the most highly cited researchers of 2022. In 2022, 6,938, or about 0.1%, of the world's researchers earned this distinction in 21 research fields. This is the eighth consecutive year for Dr. Austin to be honoured.

11/15/2022

Clarivate Analytics Highly Cited Researchers 2017

2017: Dr. Peter Austin was selected by Clarivate Analytics as one the most highly cited researchers of 2017. This annual list identifies researchers who have published a high number of papers that rank within the top 1% of most-cited works in their field during its year of publication.

11/15/2017

Thomson Reuters’ 2016 Highly Cited Researchers

2016: Dr. Peter Austin was selected by Thomson Reuters as one the most highly cited researchers of 2016. These reports rank among the top 1% most cited works for their subject field and year of publication, earning them the mark of exceptional impact.

11/18/2016

Recent ICES Publications

11/11/2022

Predicting left main stenosis in stable ischemic heart disease using logistic regression and boosted trees

Godoy LC, Farkouh ME, Austin PC, Shah BR, Qiu F, Sud M, Wijeysundera HC, Mancini JBG, Ko DT. Am Heart J. 2022; Nov 11 [Epub ahead of print]. DOI: https://doi.org/10.1016/j.ahj.2022.11.004

11/5/2022

Trial of an intervention to improve acute heart failure outcomes

Lee DS, Straus SE, Farkouh ME, Austin PC, Taljaard M, Chong A, Fahim C, Poon S, Cram P, Smith S, McKelvie RS, Porepa L; for the COACH Trial Investigators. N Engl J Med. 2022; Nov 5 [Epub ahead of print]. DOI: https://doi.org/10.1056/NEJMoa2211680

11/4/2022

Association between concurrent use of amiodarone and DOACs and risk of bleeding in patients with atrial fibrillation

Shurrab M, Jackevicius CA, Austin PC, Tu K, Qiu F, Singh SM, Crystal E, Caswell J, Michael F, Andrade JG, Ko DT. Am J Cardiol. 2022; Nov 4 [Epub ahead of print]. DOI: https://doi.org/10.1016/j.amjcard.2022.10.031

Peter Austin

Education

Research Focus

Other Affiliations

Recent ICES Grants